MedTrace Logo

Transcend Auto vs Commercially Available Device Clinical Evaluation for Treatment of Obstructive Sleep Apnea (OSA)

NCT01799265 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2025-01-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether the Transcend Auto is as effective in treating obstructive sleep apnea as another device that is already on the market.

Conditions

Interventions

DEVICE

Somnetics Transcend Auto

DEVICE

Respironics REMstar Auto with C-Flex

Sponsors & Collaborators

  • Somnetics International, Inc.

    lead INDUSTRY

Principal Investigators

  • Eric Powell, PhD RPSGT · Sleep Therapy and Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-27
Primary Completion
2013-06-10
Completion
2013-06-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01799265 on ClinicalTrials.gov